Dynamics of the Cranial Electrotherapy Stimulation Devices Market

ces-ultra

With the increasingly stressful lifestyle there is also rise in other types of disorders such as anxiety and sleep disorders. With the lack of sufficient treatments that address these disorders, cranial electrotherapy stimulation comes as an innovative and required treatment.

Cranial Electrotherapy Stimulation (CES) device is a small device that stimulates the cranium and brain with a current less than 4 mA, which cannot be sensed by the patient. The cranial electrotherapy stimulation is approved by the FDA for the treatment of insomnia, depression and anxiety. Besides, it has potential application in the treatment of a number of disorders such as attention deficit hyperactivity disorder (ADHA), obsessive-compulsive disorder, post-traumatic stress disorder (PTSD), cognitive dysfunction, traumatic brain injury, pain, enhancing attention and concentration, and for reducing assaultive behavior.

A relatively large number of the population across the globe is diagnosed with such disorders. A significant portion of the U.S. population is affected by poor mental health, which leads to development of various kinds of mental health disorders. The treatment method is complementary and an alternative of medicine. There are large number of clinical trials currently active, which have proved the CES device as an effective treatment method.

The increasing number of cases of poor mental health with the development of disorders such as depression, anxiety and other sleep disorders is driving the growth of the market. Although animal studies have proved this device to be effective, the adoption of these devices is affected due to lack of strong evidence in humans proving the efficacy of the devices in all or most of the cases. However, there are a number of new clinical trials in the recruiting stage, which may help fill the gap in the market.

Use of Cranial Electrotherapy Stimulation in Hospitals and the Growing Demand of Wearable Type of Devices

There are various types of cranial electrotherapy stimulator devices and they can be broadly classified based on the type of electrode placement, such as invasive or transcranial and non-invasive or wearable. The wearable type is the dominant segment in the market. The wearable type device is user-friendly and does not requires surgical insertion of the electrode. Most of the FDA-approved devices are suitable for the treatment of insomnia, depression and anxiety, as the prevalence of these disorders is increasing, in which depression is the most common and growing disorder in the young population. Since most of these devices are available only in prescribed hospitals and mental health clinics, they have a large scope as end-use segments in the market.

The CES Ultra is one of the three major cranial electrotherapy stimulation devices, namely the CES Ultra by Neuro-fitnesss LLC, Alpha-Stim M and the Alpha-Stim AID by Electromedical Products International (EPI), and the Fisher-Wallace Simulator.

The CES Ultra is most affordable and effective easy to use CES device. You can buy directly from us, Neuro-fitnesss LLC, the manufacturer, without a middleman, and save time and money.

Why Pay More?

A few words of advice if you’re looking to purchase a CES unit: There are only a few FDA approved companies selling CES in the U.S. Here are the companies and their devices:

  • Neuro-Fitness LLC/ CES Ultra
  • Fisher Wallace, Inc./Fisher-Wallace Stimulator
  • Electromedical Products International, Inc./Alpha-Stim

Below is a price comparison table:

ces-devices-prices

Do not be fooled into paying more, because you think more is better. The FDA (Food and Drug Administration) considers all approved CES units to be “substantially equivalent” to each other.

Note: *The CES Ultra is the premier unit on the market. It alone features the original 100 Hz configuration that most of the CES research has been done on. Other units may claim to carry the 100 Hz but no other unit has an accurate rendition of the configuration on which most of the research is based.

WARNING

Do not buy product that are not approved by FDA (The Food and Drug Administration)

You may also find certain “underground” instruments on the market, particularly on the Internet. Contrary to their anecdotal claims, most have no scientific evidence behind them. Many are nothing more than low-cost pulse generators of dubious quality, and have not been fully evaluated for either efficacy or safety. They are not registered with the FDA. Many are billed as “for research purposes only,” and cannot legally be called “medical devices” or make any medical claims. Many are from overseas and are of dubious quality.

Student received a big boost through CES Ultra

Vignette # 8

ces-student-test

Sarah, a seventeen year old female in the eleventh grade, states “Now I take more time to think about things (i.e. vocabulary words) and I spend more time and take more steps to remember them than before”. She is also reported to take more time to insure she has followed all the necessary steps and test taking skills in biology and history are improved in her improved ability to completely read questions and formulating better thought out written answers.

She reports wearing the device while taking tests “It relaxed me. I remember coming into the class with a headache. By the time I finished the test the headache was gone.”

After working daily with an educational therapist for fifteen days with application of the CES device for at least
forty-five minutes daily she was successful for the first time in memorizing two pages of lines in a skit, demonstrated improved math skills and comprehension of biology concepts. Sarah states that she would not have been able to accomplish this without the use of the device. Self confidence also improved and fear of test taking was greatly decreased if not eliminated. Her grades are now in the B range where formerly they were in the D to F range. intervention was also associated with the cessation of a difficult premenstrual tension syndrome. She reports no further menstrual cramps since using the device and states “I am not witchy anymore” during her menstrual periods. She states that she is no longer bothered by the chronic fatigue that so dramatically affected her earlier learning efforts.

Anti-anxiety pills could be next U.S. drug epidemic

Anxiety disorders are the most common mental illness in the U.S., affecting 40 million adults in the United States age 18 and older, or 18.1% of the population every year.

anti-anxiety-pills

Considered relatively safe and non-addictive by consumers and many doctors, Xanax, Valium, Ativan and Klonopin have been prescribed to millions of Americans for decades to calm jittery nerves and promote a good night’s sleep. But the number of people taking the sedatives and the average length of time they’re taking them have shot up since the 1990s, when doctors also started liberally prescribing opioid painkillers.

Actually anti-anxiety pills are not so safe. Due to their high potency, benzodiazepines can change the brain’s neurochemistry. Over time, the drugs build up in the user’s body. Users can develop mental and physical dependencies on the drugs as a result.

Prescriptions have increased more than 60 percent in the last two decades and overdose deaths involving them have more than quadrupled between 2002 and 2015, promptings some states to limit the number of pills a patient can be prescribed.

The growing use of anti-anxiety pills reminds some doctors of the early days of the opioid crisis. Benzodiazepines, or “benzos,” are a class of pharmaceutical drugs prescribed for a spectrum of mental disorders and ailments. They are used to treat moderate to severe anxiety, panic attacks, epileptic seizures and even withdrawal symptoms from other central nervous system depressants like alcohol. Benzodiazepines are legal when they are prescribed. However, a black market for the drugs exists as well. On the street, benzodiazepine drugs might go by other names like tranks, downers or simply benzos.

State and federal officials are now warning that excessive prescribing of a class of drugs known as benzodiazepines or “benzos” is putting more people at risk of dependence on the pills and is exacerbating the fatal overdose toll of painkillers and heroin. When taken in combination with painkillers or illicit narcotics, benzodiazepines can increase the likelihood of a fatal overdose as much as tenfold, according to the National Institute on Drug Abuse. On their own, the medications can cause debilitating withdrawal symptoms that last for months or years. As prescriptions for benzodiazepines have grown since the late 1990s, so have deaths, according to a study at Montefiore Medical Center in New York. The National Institute on Drug Abuse reports that overdose deaths involving benzodiazepines quadrupled from 2002 to 2015.

Benzodiazepines are a fantastic medication to deal with and to cope with infrequent and unnatural experiences. These anxiety drugs should only be reserved for infrequent procedures like a colonoscopy, or extensive dental procedure.

We don’t need chemicals to get us through the painful events of life. This is about a 20-30 year old phenomena in the US where we feel we need to cope with life using chemicals to get us through traumatic issues. Once It becomes a coping mechanism to deal with your life, we have to question what we are doing here.

While opioids’ toxic effects are respiratory depression, benzos also depress your breathing and can be fatal. The body becomes so relaxed and euphoric from drugs like Xanax, that it doesn’t feel the need to breathe, he said. Patients end up dying from an “overdose of pleasure.” In a lot of ways benzos mimic the pharmacology of alcohol. It impairs memory, it impairs cognitive ability, and literally lowers your IQ and ability to function.

Public health officials warn that people who abruptly stop taking benzodiazepines risk seizures or even death. Opioid withdrawal will make you want to die, but typically won’t kill you. Benzo withdrawal on the other hand can create withdrawal seizures that can be life threatening.

Further statistics show:

  • 65% of North Americans take prescription medications daily, 43% take mood altering prescriptions regularly.
  • There were over 3.3 Billion prescriptions filled in America in 2002 (12 times the U.S’s population – that’s 12 prescriptions for every man, woman, and child in the U.S. that year).
  • Paxil and Zoloft (two of the more popular anti-anxiety medications) ranked 7th and 8th in the top ten prescribed medications in the US (these two medications totaled almost $5 Billion in sales in 2002).

People need to rely more on talk therapy or alternative medicine to cope with their anxiety and distress, instead of counting on a magic pill.

Cranial Electortherapy Stimulation (CES) is a safe alternative to drugs. CES is a unique and viable “bioelectric” approach which enhances the homeostasis of the biological central nervous system – the tendency for intrinsic balance within a system. Isn’t it time we examined a drug-free alternative? Cranial Electrotherapy is exactly that — an effective modality with no negative side-effect.

ref:> yellowhammernews.com/addiction-expert | health.com/anxiety | anxietycentre.com

Pharmaceuticals NO, Electroceuticals YES

Electroceuticals are a new category of therapeutic agents which act by targeting the neural circuits of organs. The therapy involves mapping the neural circuitry and delivering neural impulses to these specific targets.

ces-electroceuticals

Currently drugs rule the roost. Whatever cannot be treated by drugs is treated by interventions or surgery. Technically, all organs and functions are regulated through brain and nervous system; a circuits of neurons communicating through neural impulses. Even endocrine system is under control of central nervous system by a complex array of feed-back mechanisms. Furthermore, most drugs effect by either acting on final-receptors (neural) or endocrine mechanisms. But all known drugs and of-course surgeries or non-surgical interventions have definite side-effects, because their action cannot be exactly localized to the defective part or organ. In this context, imagine a day when instead of drugs, electrical impulses become the mainstay of medical therapy.
Instead of administering drugs, or doing complex procedures, the physicians may just administer electroceuticals which will target individual nerve fibres or specific brain circuits and be able to treat any condition. In other words, the neural impulses that control the body will be entrained to regain the lost function and reestablish a healthy balance. Thus they could regulate a host of bodily activities; food intake, cardiac activity, pancreatic activity, liver, kidney or spleen functions. They could even control inflammation and set right many pathologies like diabetes mellitus, obesity, hypertension, heart failure, cerebro-vascular and pulmonary diseases.

It is estimated that electroceuticals will become a mainstay of medical treatment over the next two decades, benefiting up to 2 billion people – a quarter of the global population – who are suffering from chronic diseases.
Electroceuticals is a recently coined term for an old therapeutic modality that broadly encompasses all bioelectronic medicine. It incluses any type of electrical stimulation to affect and modify functions of the body; neural implants such as cochlear implants, retinal implants or spinal cord stimulators for pain relief but also cardiac pacemakers and implantable defibrillators. Recently, the field has expanded to include deep brain stimulation and the electrical stimulation of the vagus nerve including cranial electrotherapy stimulation (CES).

CES work because the nervous system and tissues function electrochemically and can be modulated readily by electrical intervention. Low-frequency current effectively targets cell receptors, activating them through frequency matching in a manner similar to that of chemical ligands.

The sensation of pain is transmitted through the body along billions of nerve cells that are designed specifically to transmit messages through electrochemical signals. Physics controls chemical reactions in the body, and most bodily functions can be normalized electrically. It is the application protocol that affects the peripheral pain site directly and accesses the central nervous system by directing the current through the spine. Combining MET and CES addresses all 4 pain pathways: transduction, transmission, modulation, and perception.

The resultant central and peripheral effects of CES include calmness, relaxation, reduced agitation and aggression, stabilized mood, improved sleep, and reduced pain. Results will vary with the exact technology used, the pathology of the disease being treated, the overall health and hydration of the patient.
Therapeutically, electroceuticals score over conventional drugs in a number of ways. Number one, they target neural electrical circuits which are composed of discrete elements; a system of – interconnected cells, nerve fibre network and nerve bundles, thus allowing for precise application of therapeutic effort. The final common pathway of this whole circuit is generation of action potential which itself can be modified allowing for additional control. Thus overall, efficacy increases but side effects decrease because of extreme specificity of response.

Ref>
https://www.sciencedirect.com/science/article/pii/S0019483217308131
https://www.americanveterinarian.com/journals/amvet/2018/july2018/electroceuticals-the-wave-of-the-future-is-now